195 related articles for article (PubMed ID: 7395964)
1. A differential effect of C5a and C5a des Arg in the induction of pulmonary inflammation.
Larsen GL; McCarthy K; Webster RO; Henson J; Henson PM
Am J Pathol; 1980 Jul; 100(1):179-92. PubMed ID: 7395964
[TBL] [Abstract][Full Text] [Related]
2. Induction of lysosomal enzyme secretion by alveolar macrophages in response to the purified complement fragments C5a and C5a des-arg.
McCarthy K; Henson PM
J Immunol; 1979 Dec; 123(6):2511-7. PubMed ID: 574148
[TBL] [Abstract][Full Text] [Related]
3. Complement fragments, alveolar macrophages, and alveolitis.
Henson PM; McCarthy K; Larsen GL; Webster RO; Giclas PC; Dreisin RB; King TE; Shaw JO
Am J Pathol; 1979 Oct; 97(1):93-110. PubMed ID: 495697
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary injury induced by C3a and C5a anaphylatoxins.
Stimler NP; Hugli TE; Bloor CM
Am J Pathol; 1980 Aug; 100(2):327-48. PubMed ID: 6967702
[TBL] [Abstract][Full Text] [Related]
5. Lung inflammation induced by complement-derived chemotactic fragments in the alveolus.
Shaw JO; Henson PM; Henson J; Webster RO
Lab Invest; 1980 May; 42(5):547-58. PubMed ID: 7382429
[TBL] [Abstract][Full Text] [Related]
6. In vivo clearance and tissue distribution of C5a and C5a des arginine complement fragments in rabbits.
Webster RO; Larsen GL; Henson PM
J Clin Invest; 1982 Dec; 70(6):1177-83. PubMed ID: 7174788
[TBL] [Abstract][Full Text] [Related]
7. Chemotactic responses of human peripheral blood monocytes to the complement-derived peptides C5a and C5a des Arg.
Marder SR; Chenoweth DE; Goldstein IM; Perez HD
J Immunol; 1985 May; 134(5):3325-31. PubMed ID: 3884709
[TBL] [Abstract][Full Text] [Related]
8. Human C5a des Arg increases vascular permeability.
José PJ; Forrest MJ; Williams TJ
J Immunol; 1981 Dec; 127(6):2376-80. PubMed ID: 6170701
[TBL] [Abstract][Full Text] [Related]
9. A direct in vivo comparison of the inflammatory properties of human C5a and C5a des Arg in human skin.
Swerlick RA; Yancey KB; Lawley TJ
J Immunol; 1988 Apr; 140(7):2376-81. PubMed ID: 3351304
[TBL] [Abstract][Full Text] [Related]
10. Attachment of human C5a des Arg to its cochemotaxin is required for maximum expression of chemotactic activity.
Perez HD; Chenoweth DE; Goldstein IM
J Clin Invest; 1986 Dec; 78(6):1589-95. PubMed ID: 3782473
[TBL] [Abstract][Full Text] [Related]
11. C5a induction of human interleukin 1. Synergistic effect with endotoxin or interferon-gamma.
Okusawa S; Dinarello CA; Yancey KB; Endres S; Lawley TJ; Frank MM; Burke JF; Gelfand JA
J Immunol; 1987 Oct; 139(8):2635-40. PubMed ID: 3116090
[TBL] [Abstract][Full Text] [Related]
12. Airways hyperreactivity and inflammation produced by aerosolization of human C5A des arg.
Irvin CG; Berend N; Henson PM
Am Rev Respir Dis; 1986 Oct; 134(4):777-83. PubMed ID: 3767132
[TBL] [Abstract][Full Text] [Related]
13. The in vivo effect of leukotriene B4 on polymorphonuclear leukocytes and the microcirculation. Comparison with activated complement (C5a des Arg) and enhancement by prostaglandin E2.
Movat HZ; Rettl C; Burrowes CE; Johnston MG
Am J Pathol; 1984 May; 115(2):233-44. PubMed ID: 6326579
[TBL] [Abstract][Full Text] [Related]
14. Quantification of chemotactic peptides (C5a anaphylatoxin and IL-8) in psoriatic lesional skin.
Takematsu H; Tagami H
Arch Dermatol; 1993 Jan; 129(1):74-80. PubMed ID: 8420495
[TBL] [Abstract][Full Text] [Related]
15. Time course of quartz and TiO(2) particle-induced pulmonary inflammation and neutrophil apoptotic responses in rats.
Zhang DD; Hartsky MA; Warheit DB
Exp Lung Res; 2002 Dec; 28(8):641-70. PubMed ID: 12490038
[TBL] [Abstract][Full Text] [Related]
16. Cessation of neutrophil influx in C5a-induced acute experimental arthritis is associated with loss of chemoattractant activity from the joint space.
Haslett C; Jose PJ; Giclas PC; Williams TJ; Henson PM
J Immunol; 1989 May; 142(10):3510-7. PubMed ID: 2715634
[TBL] [Abstract][Full Text] [Related]
17. Human C5a and C5a des Arg exhibit chemotactic activity for fibroblasts.
Senior RM; Griffin GL; Perez HD; Webster RO
J Immunol; 1988 Nov; 141(10):3570-4. PubMed ID: 3183381
[TBL] [Abstract][Full Text] [Related]
18. Demonstration of C5 cleaving activity in bronchoalveolar fluids and cells: a mechanism of acute and chronic alveolitis.
Desai U; Dickey B; Varani J; Kreutzer DL
J Exp Pathol; 1984; 1(3):201-16. PubMed ID: 6400640
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of the chemotactic activity of human C5a des Arg by an anionic polypeptide ("cochemotaxin") in normal serum and plasma.
Perez HD; Goldstein IM; Webster RO; Henson PM
J Immunol; 1981 Feb; 126(2):800-4. PubMed ID: 7451994
[TBL] [Abstract][Full Text] [Related]
20. Biologically active complement (C5)-derived peptides and their relevance to disease.
Perez HD
Crit Rev Oncol Hematol; 1984; 1(3):199-225. PubMed ID: 6241542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
